Developed and produced by Jiangsu Cowin Biotech, located in the Taizhou Medical High-tech Zone and engaged in the research and production of biological reagents, a landmark cancer detection kit was recently approved for sale.
The human Septin9, SDC2 and NDRG4 gene methylation detection kit (fluorescence PCR method) got the green light.
This is the first Class III registration certificate for China's freeze-dried colorectal cancer methylation detection kit, filling a gap in the industry.
The detection of methylation of the three target genes Septin9, SDC2 and NDRG4 makes the detection results more reliable.
Methylation testing for colorectal cancer can provide early screening, prevent cancer transformation, reduce high-risk populations for early diagnosis and treatment and reduce treatment costs for patients.
An exterior view of the premises of Jiangsu Cowin Biotech. [Photo/WeChat account: weigg6666]
Engaged in the fields of life sciences and health, manufacturer Jiangsu Cowin Biotech is committed to becoming a one-stop solution provider integrating the research and development, production and sales of molecular diagnostic reagents and their raw materials, as well as third-party medical testing services.
It is striving to provide innovative biological products and services for global life science research, genetic testing and for in vitro diagnostics users.